UY36020A - ALFA INHIBIN ANTIGEN, ALFA INHIBINE CODING GENE, FUSION PROTEIN CODING GENE, ALFA INHIBINE ANTIGEN OBTAINING PROCESS, ANTIGEN COMPOSITION, ALFA INHIBIN ANTIGEN USE AND ANTIGEN COMPOSITION - Google Patents
ALFA INHIBIN ANTIGEN, ALFA INHIBINE CODING GENE, FUSION PROTEIN CODING GENE, ALFA INHIBINE ANTIGEN OBTAINING PROCESS, ANTIGEN COMPOSITION, ALFA INHIBIN ANTIGEN USE AND ANTIGEN COMPOSITIONInfo
- Publication number
- UY36020A UY36020A UY0001036020A UY36020A UY36020A UY 36020 A UY36020 A UY 36020A UY 0001036020 A UY0001036020 A UY 0001036020A UY 36020 A UY36020 A UY 36020A UY 36020 A UY36020 A UY 36020A
- Authority
- UY
- Uruguay
- Prior art keywords
- antigen
- alfa
- inhibin
- inhibine
- coding gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmacology & Pharmacy (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a una proteína inhibina alfa modificada, sus fragmentos antigénicos y proteína de fusión comprendiendo la misma, así como a su proceso de producción e a sus usos; a una composición antigénica comprendiendo los mismos, y a su uso en el aumento de la ovulación de animales, especialmente mamíferos y aves. La invención se fundamenta en la modificación de la secuencia madura de la subunidad alfa de la inhibina de Bos taurus, e n el segmento de la extremidad C-terminal que pasa a tener las dos regiones más inmunogénicas en ese segmento.The invention relates to a modified alpha inhibin protein, its antigenic fragments and fusion protein comprising the same, as well as its production process and its uses; to an antigenic composition comprising the same, and to its use in the increase of ovulation of animals, especially mammals and birds. The invention is based on the modification of the mature sequence of the alpha subunit of Bos taurus inhibin, in the segment of the C-terminal limb that happens to have the two most immunogenic regions in that segment.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102014005376A BR102014005376A2 (en) | 2014-03-07 | 2014-03-07 | inhibin alpha antigen, inhibin alpha coding gene, fusion protein encoding gene, process of obtaining inhibin alpha antigen, antigenic composition, use of inhibin alpha antigen, and use of antigenic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
UY36020A true UY36020A (en) | 2015-09-30 |
Family
ID=54054284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001036020A UY36020A (en) | 2014-03-07 | 2015-03-05 | ALFA INHIBIN ANTIGEN, ALFA INHIBINE CODING GENE, FUSION PROTEIN CODING GENE, ALFA INHIBINE ANTIGEN OBTAINING PROCESS, ANTIGEN COMPOSITION, ALFA INHIBIN ANTIGEN USE AND ANTIGEN COMPOSITION |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR099671A1 (en) |
BR (1) | BR102014005376A2 (en) |
UY (1) | UY36020A (en) |
WO (1) | WO2015131254A1 (en) |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1341617C (en) * | 1984-06-08 | 2011-06-28 | Henry George Burger | Inhibin isolated from ovarian follicular fluid |
KR940004077B1 (en) * | 1985-04-18 | 1994-05-11 | 바이오테크놀로지 오스트레일리아 프로프라이어터리 리밋티드 | Recombinantinhbin |
US5215893A (en) * | 1985-10-03 | 1993-06-01 | Genentech, Inc. | Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
NZ217727A (en) * | 1985-10-03 | 1990-05-28 | Genentech Inc | Nucleic acid encoding alpha or b chain of inhibin, its production and compositions containing it |
US4864019A (en) * | 1985-11-08 | 1989-09-05 | The Salk Institute For Biological Studies | Antibodies to inhibin and conjugates produced therefrom |
ES2065673T3 (en) * | 1990-01-08 | 1995-02-16 | Genentech Inc | PROCEDURE TO INCREASE FERTILITY IN FEMALES. |
US20040220098A1 (en) * | 1994-02-28 | 2004-11-04 | Satterlee Daniel G. | Inhibin compositions and methods of enhancing fertility and growth |
PT804219E (en) * | 1994-02-28 | 2002-12-31 | Agritech Technologies Ltd | INIBINE COMPOSITIONS AND METHODS FOR THEIR USE |
JPH07238097A (en) * | 1994-09-07 | 1995-09-12 | Masao Igarashi | Igg antibody comprising inhibin as antigen |
JP2899534B2 (en) * | 1994-12-09 | 1999-06-02 | 全国農業協同組合連合会 | Method of inducing superovulation in cattle |
JP2006523180A (en) * | 2002-11-07 | 2006-10-12 | アグリテック テクノロジー リミテッド | Novel inhibin-related multi-antigen peptide composition that promotes productivity in birds |
BRPI0506043A (en) * | 2005-07-12 | 2007-03-13 | Univ Fed Do Rio Grande Do Sul | animal evaluation and selection process |
CN101407781A (en) * | 2008-12-01 | 2009-04-15 | 华中农业大学 | Inhibin DNA vaccine capable of improving animal fertility, and preparation and use thereof |
-
2014
- 2014-03-07 BR BR102014005376A patent/BR102014005376A2/en not_active Application Discontinuation
-
2015
- 2015-03-04 WO PCT/BR2015/050025 patent/WO2015131254A1/en active Application Filing
- 2015-03-05 AR ARP150100658A patent/AR099671A1/en unknown
- 2015-03-05 UY UY0001036020A patent/UY36020A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR099671A1 (en) | 2016-08-10 |
WO2015131254A1 (en) | 2015-09-11 |
BR102014005376A2 (en) | 2016-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2019010503A2 (en) | Custom immunogenic peptide identification platform | |
CO2017009061A2 (en) | Variant polypeptides of the immunoglobulin degradation enzyme g of s. pyogenes | |
CL2021002994A1 (en) | Novel antibodies that specifically bind to Zika virus epitopes and their uses. (divisional application no. 201900067) | |
CL2016001968A1 (en) | Interleukin-2 fusion proteins and uses thereof | |
CO2018011804A2 (en) | Flt3 chimeric receptors and methods of use thereof | |
CO2018009995A2 (en) | Binding proteins and methods of use thereof | |
GEP20217326B (en) | Constructs having a sirp-alpha domain or variant thereof | |
CO2017000507A2 (en) | Chimeric bcma antigen receptor | |
CO2017000510A2 (en) | Car constructs | |
CO2017009060A2 (en) | Hybrid polypeptide of the immunoglobulin degradation enzyme g of s. pyogenes and immunoglobulin g degradation enzyme of streptococcus equi ssp. zooepidemicus | |
CO2017000506A2 (en) | Chimeric cll-1 antigen receptor | |
CL2017000651A1 (en) | Anti-glucagon antibodies and their uses | |
ECSP18096095A (en) | ALPHA-SINUCLEIN ANTIBODIES AND USES OF THEM | |
BR112019010275A2 (en) | recombinant adenovirus, composition, use of adenovirus or composition, method of inducing an immune response in a patient, and non-human simian adenovirus | |
BR112016028891A2 (en) | seed train processes and uses | |
UY36021A (en) | FC MULTIMÈRIC PROTEINS | |
CL2016000538A1 (en) | Compound comprising the h and klh balloon protein, compositions of a carbohydrate vaccine for the induction of immune responses and uses thereof | |
CO2020009402A2 (en) | Fc il-22 fusion proteins and methods of use | |
UY36006A (en) | USPA2 PROTEIN CONSTRUCTIONS AND USES OF THE SAME. | |
CL2017000053A1 (en) | Β-protofibril binding antibodies | |
PE20171076A1 (en) | COMPOSITION CONTAINING CHITIN AND DIGERIBLE PROTEINS | |
EA201692279A1 (en) | METHOD FOR REDUCING IMMUNOGENIC PROTEIN AND PEPTIDE | |
PE20151978A1 (en) | NUTRITIONAL COMPOSITIONS CONTAINING A PEPTIDIC COMPONENT WITH ANT-INFLAMMATORY PROPERTIES AND USES OF THE SAME | |
CL2019002323A1 (en) | Il-13ra2 antibody and its use. | |
CR20160593A (en) | Interferon alpha and omega antibody antagonists. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20220610 |